About us
Who we are
Our strategy
How we are funded
Our people
Governance and structure
Reports and statements
Our impact
Suppliers
Our strategy
Our strategy
Neurodegeneration
Respiratory health
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease research funding
Development Gap Fund
Current funding opportunities
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
Students and fellows
How to apply
Job vacancies
News
Latest news
Case studies
Reports and publications
Newsletter
Neurodegeneration
Over 1 million people are living with neurodegenerative diseases in the UK alone
Home
Our strategy
Neurodegeneration
We’re investing up to £100m to tackle neurodegenerative conditions
MND Translational Challenge
LifeArc’s multi-million-pound programme to accelerate scientific innovation for people living with MND.
MND Collaborative Partnership
Read about our landmark partnership with MND charities and government funders to develop effective MND treatments faster.
Supporting dementia research
A £30m partnership with UKDRI to accelerate development of new treatments for people with dementia.
Sign up for news
Sign up to receive email updates on our progress with the MND Translational Challenge.
Contact
Get in touch with LifeArc